eISSN: None / ISSN: 1673-5269
Register
Login
Volume 31 Issue 21 (2024): None
Articles
Research progress on Interleukin-6 and its role in the treatment of hepatocellular carcinoma; 白介素-6 与肝细胞癌治疗的研究进展
1340-1346
Research progress on experimental model of malignant pleural mesothelioma; 恶性胸膜间皮瘤实验模型研究进展
1333-1339
Production of actinium-225 and its clinical application in tumor targeted therapy; 锕-225 的生产及在肿瘤靶向治疗中的应用
1326-1332
Predictve value of the lymphocyte to C-reactive protein ratio and immune-related adverse events for the survival prognosis of patients with extensive stage-small cell lung cancer; 淋巴细胞/C 反应蛋白比值和免疫相关不良反应对广泛期小细胞肺癌患者生存预后的预测价值研究
1306-1315
Evaluation of the protection of Bach1 gene knockout against doxorubicin-induced cardiotoxicity based on 9. 4T cardiovascular magnetic resonance feature-tracking; 9.4T 心脏磁共振特征追踪成像评估敲除 Bach1 基因对多柔比星诱导心脏毒性的保护
1298-1305
Effect of long non-coding RNA OIP5-AS1 on migration and invasion of laryngeal squamous cell carcinoma via miR-216a-5p/ZEB1 axis; 长链非编码 RNA OIP5-AS1 通过 miR-216a-5p/ZEB1 轴对喉鳞状细胞癌迁移和侵袭影响
1291-1297
Short-term effects of PM2.5, O3 and CO on lung cancer mortality among residents in Pudong New Area; 大气细颗粒物和臭氧及一氧化碳短期效应对浦东新区居民肺癌死亡的影响分析
1285-1290

For any inquiries regarding the journal, publication process, or manuscript status, please contact the Editorial Office at support@cjcpt.org.

 

Authors are requested to submit their manuscripts and related documents via email at submission@cjcpt.org

 

Address: Jinan, Shandong Province, Ji Yan Road #440 - Location

 

Please contact us on WhatsApp: https://wa.me/447460013985 

Open Access Publication